BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 19351019)

  • 1. [Antibacterial therapy of outhospital pneumonia in military treatment-prophylactic institutions].
    Sinopal'nikov AI; Rachina SA; Iashchenko AV; Shal' EP
    Voen Med Zh; 2009 Feb; 330(2):14-20. PubMed ID: 19351019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibacterial therapy of out-hospital pneumonia in military prophylaxis-treat-29 ment institutions and hospitals].
    Zaĭtsev AA; Chudnova EV; Klochkov OI
    Voen Med Zh; 2007 Aug; 328(8):29-35. PubMed ID: 18154161
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
    Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
    Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of recent studies of community-acquired pneumonia.
    Higgins K; Singer M; Valappil T; Nambiar S; Lin D; Cox E
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S150-6. PubMed ID: 18986282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical efficacy of probiotics in complex treatment of called-up servicemen with community-acquired pneumonia].
    Rakov AL; Grinevich VB; Kriukov AE; Bogdanov IV; Rysev AV; Zakharchenko MM; Dobrenko VA; Gubonina IV
    Voen Med Zh; 2006 Apr; 327(4):15-22. PubMed ID: 16784101
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
    Niven DJ; Laupland KB
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy or combination therapy for hospitalized patients with community-acquired pneumonia: not yet the end of the story?
    Laterre PF
    Clin Infect Dis; 2008 May; 46(10):1510-2. PubMed ID: 18419483
    [No Abstract]   [Full Text] [Related]  

  • 8. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
    Esposito S; Fiore M
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic therapy for community-acquired pneumonia with septic shock: follow the guidelines.
    Blot S; Depuydt P
    Crit Care Med; 2007 Jun; 35(6):1617-8. PubMed ID: 17522537
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Japanese Respiratory Society guidelines for management of community-acquired pneumonia in adults].
    Matsushima T;
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():677-81. PubMed ID: 12722300
    [No Abstract]   [Full Text] [Related]  

  • 11. Timely antibiotic therapy for community-acquired pneumonia.
    Mansel JK
    J Miss State Med Assoc; 2004 May; 45(5):159. PubMed ID: 15162706
    [No Abstract]   [Full Text] [Related]  

  • 12. The halo effect of adherence to guidelines extends to patients with severe community-acquired pneumonia requiring admission to an intensive care unit.
    Marrie TJ
    Clin Infect Dis; 2005 Dec; 41(12):1717-9. PubMed ID: 16288393
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical and economic aspects of treating community-acquired pneumonias].
    Tiurin VP; Dmitriev IuK; Duganov VK; Bogdanov MB
    Voen Med Zh; 2000 Apr; 321(4):28-31. PubMed ID: 10860468
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of community-acquired pneumonia Down Under versus the United States: is it really that different?
    Mandell L
    Clin Infect Dis; 2008 May; 46(10):1522-4. PubMed ID: 18419485
    [No Abstract]   [Full Text] [Related]  

  • 15. [Empirical antibacterial therapy of community acquired pneumonia in outpatients].
    Yakovlev SV; Suvorova MP
    Antibiot Khimioter; 1997; 42(10):23-8. PubMed ID: 9412399
    [No Abstract]   [Full Text] [Related]  

  • 16. [An outhospital pneumonia in patients vaccined with"Pneumo-23': peculiarities of clinics, diagnostics and treatment].
    Shepelenko AF; Stepanchenko AV; Vorobets VG
    Voen Med Zh; 2008 Sep; 329(9):44-9. PubMed ID: 19048853
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
    Nakamura S; Yanagihara K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Senjyu H; Saito A; Kohno S
    J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs of choice for community-acquired bacterial pneumonia.
    Med Lett Drugs Ther; 2007 Jul; 49(1266):62-4. PubMed ID: 17652999
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacoeconomic estimation of cost of community acquired pneumonia therapy].
    Kulidzhanov AIu; Sirotko II; Koriakin PM; Korchazhkin VS
    Voen Med Zh; 2001 Jan; 322(1):50-2. PubMed ID: 11219929
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of lower respiratory tract infections in immunocompetent adults (community-acquired pneumonia and acute exacerbation of chronic obstructive pulmonary disease): the challenge of a new consensus conference].
    Chidiac C
    Med Mal Infect; 2006 Jan; 36(1):1-3. PubMed ID: 16413722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.